Advertisement
JXN vs MET
Which Stock Would AI Choose? Jackson Financial Inc. (JXN) vs. MetLife, Inc. (MET) Stock Comparison
Key Takeaways
- JXN has delivered stronger recent momentum, with year-to-date gains of about 8% compared to MET's 2.4%, and one-year returns exceeding 50% versus 9%.
- JXN trades at a lower price-to-earnings (P/E) ratio of 15.3 versus MET's 17.0, suggesting relative value in recent market activity.
- Dividend yields favor JXN at 3.15% over MET's 2.95%, bolstered by recent hikes from both firms.
- MET provides superior scale with a $52 billion market capitalization compared to JXN's $8 billion.
- Both stocks exhibit positive sentiment ahead of first-quarter 2026 earnings, with investment income supporting outlooks.
- JXN's higher beta of 1.4 indicates greater volatility than MET's 0.73.
Introduction
Jackson Financial Inc. (JXN) and MetLife, Inc. (MET) are prominent players in the life insurance sector, offering annuities, retirement solutions, and related financial products. This stock comparison evaluates their recent performance, valuations, and market positioning amid evolving interest rates and economic conditions. Investors seeking income-generating opportunities or exposure to insurance trends—such as rising demand for annuities and stable group benefits—may find insights here valuable for assessing relative strengths in a resilient sector. Traders focused on momentum and upcoming earnings catalysts will appreciate the head-to-head analysis of these U.S.-based insurers.
JXN Overview and Recent Performance
Jackson Financial Inc. (JXN), based in Michigan, specializes in annuities and retirement income products through segments like Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. Distributed via broker-dealers and advisors, the company benefits from demand for fixed and variable annuities in a higher-rate environment. Shares recently traded around $114, within a 52-week range of $79 to $124, reflecting a market capitalization of approximately $8 billion. Recent market activity shows robust one-year gains over 50%, driven by strong investment income and a 12.5% quarterly dividend increase to $0.90 per share earlier in the year. Year-to-date performance stands at about 8%, with sentiment buoyed by anticipation for first-quarter 2026 earnings. Key metrics include a trailing P/E (price-to-earnings) ratio of 15.3 and return on equity (ROE) of 0.7%, underscoring efficient capital use amid favorable sector tailwinds.
MET Overview and Recent Performance
MetLife, Inc. (MET), headquartered in New York, operates globally in insurance, annuities, employee benefits, and asset management across segments including Group Benefits, Retirement and Income Solutions, and international markets in Asia, Latin America, and Europe. With around 46,000 employees, it provides life, health, and pension products. Shares recently hovered near $80, in a 52-week range of $67 to $84, supporting a $52 billion market cap. Recent weeks have seen modest year-to-date gains of 2.4% and one-year returns of 9%, influenced by a 4.4% dividend hike and previews of elevated variable investment income for the first quarter. Earnings expectations remain steady, with a trailing P/E of 17.0, forward P/E of 8.8, and ROE of 12%. Broader diversification has tempered volatility, fostering stable performance in fluctuating markets.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases 25 top-performing AI trading bots curated from over 350 available models that trade thousands of tickers across stocks, ETFs, and crypto. These bots employ diverse strategies like trend-following, swing trading, and multi-agent systems with take-profit/stop-loss corridors, featuring win rates from 51% to 88%, annualized returns up to 163%, profit factors between 1.5 and 11.7, and trade durations from hours to weeks. Top performers target sectors such as semiconductors, data centers, and financials, with thousands of simulated trades demonstrating adaptability to current conditions. Explore these bots to potentially enhance your trading with data-driven signals tailored to volatile markets.
Head-to-Head Comparison
JXN emphasizes U.S.-centric annuity sales, capitalizing on retirement demand, while MET leverages global diversification across benefits and emerging markets for steadier growth drivers. Valuation contrasts highlight JXN's cheaper price-to-sales (1.25 vs. 0.71) and price-to-book (0.85 vs. 1.82) ratios, though MET boasts higher ROE and revenue scale ($77 billion TTM vs. $6.8 billion). Recent momentum favors JXN amid rate-sensitive gains, but MET offers lower risk via its beta and broader exposure. Market sentiment tilts positive for both pre-earnings, with trade-offs in volatility versus stability shaping investor preferences in the insurance sector.
Tickeron AI Verdict
Tickeron’s AI currently leans toward JXN over MET in short-term positioning, citing superior price growth trends, lower valuation multiples, and consistent momentum in recent weeks. Factors like higher dividend yield and annuity sector catalysts bolster this edge, though MET's scale and stability provide a counterbalance. Observable patterns suggest higher probability of near-term outperformance for JXN amid favorable insurance dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JXN is a Hold and MET is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
JXN’s FA Score shows that 1 FA rating(s) are green whileMET’s FA Score has 1 green FA rating(s).
- JXN’s FA Score: 1 green, 4 red.
- MET’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
JXN’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
- JXN’s TA Score: 4 bullish, 6 bearish.
- MET’s TA Score: 5 bullish, 4 bearish.
Price Growth
JXN (@Life/Health Insurance) experienced а -2.62% price change this week, while MET (@Life/Health Insurance) price change was +2.96% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.01%. For the same industry, the average monthly price growth was +1.29%, and the average quarterly price growth was +6.80%.
Reported Earning Dates
JXN is expected to report earnings on Aug 11, 2026.
MET is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Life/Health Insurance (+0.01% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| JXN | MET | JXN / MET | |
| Capitalization | 7.66B | 51.3B | 15% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 3.875 | 2.567 | 151% |
| P/E Ratio | 15.31 | 15.43 | 99% |
| Revenue | 5.7B | 76B | 7% |
| Total Cash | 54.1B | N/A | - |
| Total Debt | 4.57B | 20.2B | 23% |
MET | ||
|---|---|---|
OUTLOOK RATING 1..100 | 77 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 43 Fair valued | |
PROFIT vs RISK RATING 1..100 | 44 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| JXN | MET | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 63% | 3 days ago 62% |
| Stochastic ODDS (%) | 3 days ago 69% | 3 days ago 60% |
| Momentum ODDS (%) | 3 days ago 68% | 3 days ago 56% |
| MACD ODDS (%) | 3 days ago 76% | 3 days ago 66% |
| TrendWeek ODDS (%) | 3 days ago 64% | 3 days ago 56% |
| TrendMonth ODDS (%) | 3 days ago 79% | 3 days ago 48% |
| Advances ODDS (%) | 20 days ago 77% | 3 days ago 62% |
| Declines ODDS (%) | 5 days ago 63% | 7 days ago 56% |
| BollingerBands ODDS (%) | 3 days ago 67% | 3 days ago 66% |
| Aroon ODDS (%) | 3 days ago 74% | 3 days ago 45% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NZUS | 37.88 | N/A | N/A |
| Stt Strt® SPDR® MSCI USA ClmtPrsAlgd ETF | |||
| SEPW | 33.06 | -0.05 | -0.14% |
| AllianzIM US Equity Buffer20 Sep ETF | |||
| JQUA | 68.07 | -0.41 | -0.60% |
| JPMorgan US Quality Factor ETF | |||
| FNY | 100.85 | -2.71 | -2.62% |
| First Trust Mid Cap Growth AlphaDEX® ETF | |||
| TEKX | 60.74 | -1.68 | -2.70% |
| State Street® Galaxy TransfTechAccelsETF | |||
JXN and
Correlation & Price change
A.I.dvisor indicates that over the last year, JXN has been closely correlated with CNO. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if JXN jumps, then CNO could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.